Trial
NCT06282861
ANTES B+ Clinical Trial
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fundacio Privada Mon Clinic Barcelona
Collaborators
GlaxoSmithKline
Condition
Chronic Obstructive Pulmonary Disease
Intervention
Trelegy Ellipta 100/62.5/25Mcg Inh 30D
Why stopped
Delays in the opening and activation of participating sites, and a low recruitment rate, with only 48 participants enrolled over the course of one year
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-14